Aptamer Group plc (APTA) ORD GBP0.0001
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Aptamer extends contract with Unilever
3 September 2024 08:06
(Sharecast News) - Custom antibody alternatives business Aptamer said on Tuesday that it has extended its contract with household goods giant Unilever to progress its Optimer asset for deodorant development.
-
Aptamer reports success in ongoing work with Unilever
8 July 2024 10:49
(Sharecast News) - Aptamer Group, a developer of novel 'Optimer' binders for the life sciences industry, updated the market on its ongoing partnership with Unilever on Monday, aimed at creating...
-
Aptamer enters partnership with Microsaic Systems
14 June 2024 14:15
(Sharecast News) - Aptamer Group announced a partnership with Microsaic Systems on Friday, to develop a panel of Optimer binders for integration into Microsaic's water testing system.
-
Aptamer sales pipeline 'strong', more than £3m in advanced discussions
13 May 2024 10:47
(Sharecast News) - Life sciences business Aptamer said on Monday that its current sales pipeline was "strong", with over £3.0m in advanced stage discussions.
-
Aptamer applies for patent over binder sequences developed with Unilever
8 April 2024 11:25
(Sharecast News) - Aptamer Group announced the submission of a patent application safeguarding newly-crafted Optimer binder sequences on Monday.
-
Aptamer reports decent technical, commercial progress
15 December 2023 11:06
(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
-
Aptamer inks £0.55m agreement with biotech firm
14 December 2023 16:43
(Sharecast News) - Aptamer Group announced a significant agreement with a biotechnology company on Thursday, focussed on genetic medicines.
-
Aptamer secures two contracts with big pharma firm
17 August 2023 15:51
(Sharecast News) - Life sciences company Aptamer Group has secured two new contracts with one of the world's top five pharmaceutical companies, it announced on Thursday, with an estimated worth of up to...
-
Aptamer announces four significant new contracts
7 July 2023 13:40
(Sharecast News) - Life sciences company Aptamer Group announced a significant update on recent contract wins on Friday, totalling up to £0.51m over the next six months.
-
Aptamer warns on profits amid slow pipeline conversion
5 May 2023 15:48
(Sharecast News) - Life sciences company Aptamer Group said in a trading update on Friday that revenue in the 10 months ended 30 April totalled around £1.4m.
-
Aptamer warns on FY revenues
3 January 2023 08:36
(Sharecast News) - Biotech company Aptamer Group warned on Tuesday that while full-year revenues may fall short of market expectations, they were still likely to come in "materially ahead" of the...
Company announcements Announcements
-
Agreement extended with genetic medicines customer
7 November 2024 07:00
Aptamer Group
-
Commercial Trading Update
6 November 2024 07:00
Aptamer Group
-
Posting of Annual Report and Notice of AGM
5 November 2024 07:00
Aptamer Group
-
Full Year Results for the 12mths to 30 June 2024
22 October 2024 07:00
Aptamer Group
-
Notice of Results and Investor Presentation
17 October 2024 07:00
Aptamer Group
-
Aptamer extends contract with Unilever
3 September 2024 07:00
Aptamer Group
-
Block listing Interim Review
27 August 2024 07:00
Aptamer Group
-
Holding(s) in Company
20 August 2024 14:26
Aptamer Group
-
TR-1: Standard form notification of major holdings
16 August 2024 13:04
Aptamer Group
-
TR-1: Standard form notification of major holdings
14 August 2024 11:34
Aptamer Group
-
Result of General Meeting and Board Changes
13 August 2024 12:57
Aptamer Group
-
Supplementary Conditional Placing for £60,000
1 August 2024 16:33
Aptamer Group
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.